TLF Q3 2026: Revenue and gross margin jump, but opex ratio remains 59% and cash declines to $5.7M

What happened

Tandy Leather Factory reported Q3 2026 revenues of $18.5 million, up 7.3% year-over-year, with gross margin expanding to 62.4% from 58.9% a year ago, driving a swing from an operating loss to positive operating income of $0.6 million and net income of $0.5 million. Adjusted EBITDA of $0.9 million signals improved operating profitability, but the company's cash balance declined to $5.7 million from $12.0 million at the end of September 2025, suggesting continued cash consumption despite earnings gains. Calculated opex as a percentage of sales remains elevated at approximately 59%, well above the 53% threshold that would indicate successful cost normalization per the DeepValue framework. The improvement in revenue growth and gross margin aligns with the upper end of management's scenarios, but the lack of disclosure on operating cash flow leaves the key thesis question unanswered. These results are a positive step but do not yet confirm a durable turnaround; the main concerns regarding fixed lease obligations and operating leverage remain unresolved.

Implication

The Q3 2026 revenue acceleration and gross margin expansion may reduce the probability of the bear case, but the still-high opex ratio and declining cash balance indicate that the company's cost structure has not yet been tamed. Investors should track quarterly operating cash flow to confirm whether positive net income translates into cash generation, as the master report's primary condition for rating upgrade is positive operating cash flow by 4Q26. If opex as a percentage of sales can be driven below 53% through further revenue growth or cost discipline, the stock's valuation multiple may re-rate upward, but current data does not support this. The decline in cash from $12 million to $5.7 million over roughly five quarters suggests that the company may be funding working capital or capex, which could constrain its ability to weather further tariff or demand shocks. Until there is evidence of sustained positive operating cash flow and improved cost leverage, the recommended stance remains WAIT, with a preference for a lower entry price near $2.25 to provide margin of safety.

Thesis delta

The Q3 2026 results show tangible improvement in revenue growth and gross margin, partially addressing the master report's concern about sales stagnation. However, the full thesis hinges on operating cash flow turning positive and opex falling below 53% of sales, neither of which is confirmed by this release; moreover, the cash balance decline suggests ongoing cash consumption. As a result, the probability distribution shifts slightly toward the bull case but not enough to change the overall WAIT rating; we need to see 4Q26 results to reassess.